Brainstorm Cell Therapeutics Inc logo

Brainstorm Cell Therapeutics Inc Share Price (NASDAQ: BCLI)

$0.65

-0.52

(-44.44%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 17 Jul 2025

Check the interactive Brainstorm Cell Therapeutics Inc Stock chart to analyse performance

Brainstorm Cell Therapeutics Inc Key Stats

Check Brainstorm Cell Therapeutics Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.17
Open
$1.23
Market Capitalization
$11.5M
Today's Volume
$221.8K
Revenue TTM
$0.0
EBITDA
$-12.1M
Earnings Per Share (EPS)
$-2.01
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1121.9%

Global Institutional Holdings in Brainstorm Cell Therapeutics Inc

  • Name

    Holdings %

  • Armistice Capital, LLC

    7.02%

  • CALDWELL SUTTER CAPITAL INC

    1.60%

  • Geode Capital Management, LLC

    0.59%

  • Vanguard Group Inc

    0.28%

  • BlackRock Inc

    0.26%

  • Liberty Wealth Management, LLC

    0.23%

Analyst Recommendation on Brainstorm Cell Therapeutics Inc Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Brainstorm Cell Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Brainstorm Cell Therapeutics Inc

Brainstorm Cell Therapeutics Inc. a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is involved in the development of NurOwn, which has completed Phase IIIb clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for treatment of other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.
Organization
Brainstorm Cell Therapeutics Inc
Employees
29
CEO
Mr. Chaim Lebovits
Industry
Electronic Technology

Key Management of Brainstorm Cell Therapeutics Inc

NameTitle
Mr. Chaim Lebovits
President & CEO
Dr. Ibrahim Dagher M.D.
Executive VP & Chief Medical Officer
Mr. Uri Yablonka
Executive VP, Chief Business Officer, Secretary & Director
Ms. Alla Patlis CPA, M.B.A.
Interim CFO & Controller
Dr. Hartoun Hartounian Ph.D.
Executive VP & COO
Dr. Daniel Offen Ph.D.
Chief Scientific Advisor
Ms. Mary Kay Turner
Senior Vice President of Patient Advocacy & Government Affairs
Dr. Netta Blondheim-Shraga Ph.D.
Senior Vice President of Research and Development

Important FAQs about investing in BCLI Stock from India :

What is Brainstorm Cell Therapeutics Inc share price today?

Brainstorm Cell Therapeutics Inc share price today is $0.65 as on at the close of the market. Brainstorm Cell Therapeutics Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Brainstorm Cell Therapeutics Inc share?

Brainstorm Cell Therapeutics Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Brainstorm Cell Therapeutics Inc stock price today i.e. is closed at $0.65, lower by 89.68% versus the 52 week high.

How to invest in Brainstorm Cell Therapeutics Inc Stock (BCLI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Brainstorm Cell Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Brainstorm Cell Therapeutics Inc Shares that will get you 2.3077 shares as per Brainstorm Cell Therapeutics Inc share price of $0.65 per share as on July 17, 2025 at 12:00 AM IST.

What is the minimum amount required to buy Brainstorm Cell Therapeutics Inc Stock (BCLI) from India?

Indian investors can start investing in Brainstorm Cell Therapeutics Inc (BCLI) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Brainstorm Cell Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on August 23, 2025). Based on Brainstorm Cell Therapeutics Inc share’s latest price of $0.65 as on July 17, 2025 at 12:00 AM IST, you will get 15.3846 shares of Brainstorm Cell Therapeutics Inc. Learn more about fractional shares .

What are the returns that Brainstorm Cell Therapeutics Inc has given to Indian investors in the last 5 years?

Brainstorm Cell Therapeutics Inc stock has given 0.0% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?